Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Colorcon
Johnson and Johnson
Deloitte
Mallinckrodt

Generated: May 24, 2019

DrugPatentWatch Database Preview

VECTIBIX Drug Profile

« Back to Dashboard

Summary for Tradename: VECTIBIX
Pharmacology for VECTIBIX
Ingredient-typeAntibodies, Monoclonal
Mechanism of ActionHER1 Antagonists

US Patents for VECTIBIX

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Roche Molecular Systems, Inc. (Pleasanton, CA) ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Tel HaShomer Medical Research Infrastructure and Services Ltd. (Ramat Gan, IL) CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Genentech, Inc. (South San Francisco, CA) ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Plexxikon Inc. (Berkeley, CA) ➤ Sign Up RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Chemo-Enhanced LLC (Woonsocket, RI) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for VECTIBIX

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C00979246/01 Switzerland ➤ Sign Up PRODUCT NAME: PANITUMUMABUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 57872 14.10.2008
SPC005/2008 Ireland ➤ Sign Up SPC005/2008: 20081105, EXPIRES: 20221202
344 Finland ➤ Sign Up
08C0006 France ➤ Sign Up PRODUCT NAME: PANITUMUMAB; REGISTRATION NO/DATE: EU/1/07/423/001 20071203
122008000009 Germany ➤ Sign Up PRODUCT NAME: PANITUMUMAB; REGISTRATION NO/DATE: EU/1/07/423/001-003 20071203
91411 Luxembourg ➤ Sign Up 91411, EXPIRES: 20221203
300335 Netherlands ➤ Sign Up 300335, 20180505, EXPIRES: 20221202
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Mallinckrodt
Express Scripts
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.